Phase
Condition
Bulimia
Binge Eating Disorder
Treatment
Observational
Clinical Study ID
Ages 18-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
men or women aged 1
participants eligible for bariatric surgery (BMI>40, or BMI>35 with severecomorbidities)
participants scheduled for medical evaluation and treatment of obesity at the IUCPQObesity Clinic (BMI≥30)
participants scheduled for evaluation and treatment of BED at the CEPIA with obesity (BMI≥30)
for the group with BED: positive BEDS-7 screen and Binge Eating Scale score >16;
for the control group: have a negative BEDS-7 screen and Binge Eating Scale score<12
be fluent in French and able to consent.
Exclusion criteria :
participants with severe neurological disorder and/or major neurocognitive deficits;
participants with previous bariatric surgery or with introduction or change ofanti-obesity medication (liraglutide or naltrexone/bupropion) in the previous 3months;
participants who cannot read and/or understand French;
participants under guardianship or curatorship;
participants already included in a study with a conflict of interest with thisstudy;
inability to use a computer or iPad;
inability to access an Internet connection or to visit one of the inclusion sites.
Exclusion
Secondary exclusion criteria:
participants with a discordance between BEDS-7 (positive) and Binge Eating Scale (score ≤ 16) results found secondarily
participants who did not participate in part of the assessments (e.g.,self-questionnaires or neurocognitive tests) and participants with a rate of missingdata>10%.
Study Design
Connect with a study center
Centre d'expertise Poids, Image et Alimentation (CEPIA)
Québec,
CanadaSite Not Available
IUCPQ
Québec,
CanadaActive - Recruiting


Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.